ICI LINDANE COCKCHAFER SPRAY EMULSIFIABLE CONCENTRATE INSECTICIDE

Main information

  • Trade name:
  • ICI LINDANE COCKCHAFER SPRAY EMULSIFIABLE CONCENTRATE INSECTICIDE
  • Class:
  • AgChem
  • Medicine domain:
  • Plants
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ICI LINDANE COCKCHAFER SPRAY EMULSIFIABLE CONCENTRATE INSECTICIDE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CUCURBIT | DAIRY OR MILKING SHED | PASTURE | ROOT VEGETABLE | BEETROOT | CANTALOUPE | CARROT | CHOKO | CUCUMBER | GHERKIN | HIGH
  • Therapeutic area:
  • INSECTICIDE
  • Therapeutic indications:
  • BLACKHEADED PASTURE COCKCHAFER | GENERAL WEED - SEE LABEL | PASTURE MOTH | ACROSSIDIUS TASMANIAE | BARNYARD GRASS | BLADY GRASS | BROME GRASS | BUFFALO GRASS | COUCH GRASS | DANDELION | FLATWEED | GUINEA GRASS | KIKUYU GRASS | LANTANA | NUTGRASS | ONION WEED | OXALIS | PASPALUM | PASTURE TUNNEL MOTH | RHODES GRASS | RYEGRASS | SORREL | ST JOHN'S WORT | WEED CONTROL - GENERAL | WINTER GRASS

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 32609
  • Last update:
  • 09-08-2016

10-10-2018

Sprayology Issues Voluntary Nationwide Recall of Homeopathic Aqueous-Based Medicines Due to Microbial Contamination

Sprayology Issues Voluntary Nationwide Recall of Homeopathic Aqueous-Based Medicines Due to Microbial Contamination

Eight and Company LLC, d/b/a Sprayology is voluntarily recalling all lots within expiry from 10/18-7/22 of its aqueous-based homeopathic product line for human use. All products manufactured by the contract manufacturer, King Bio, have been recalled due to possible microbial contamination.

FDA - U.S. Food and Drug Administration

18-12-2018


Scientific recommendation on classification of advanced therapy medicinal products: Concentrate of autologous bone marrow-derived mononuclear cells (BM-MNC)

Scientific recommendation on classification of advanced therapy medicinal products: Concentrate of autologous bone marrow-derived mononuclear cells (BM-MNC)

Scientific recommendation on classification of advanced therapy medicinal products: Concentrate of autologous bone marrow-derived mononuclear cells (BM-MNC)

Europe - EMA - European Medicines Agency

12-12-2018


Scientific recommendation on classification of advanced therapy medicinal products: Autologous concentrated bone marrow

Scientific recommendation on classification of advanced therapy medicinal products: Autologous concentrated bone marrow

Scientific recommendation on classification of advanced therapy medicinal products: Autologous concentrated bone marrow

Europe - EMA - European Medicines Agency

2-10-2018

NexoBrid (MediWound Germany GmbH)

NexoBrid (MediWound Germany GmbH)

NexoBrid (Active substance: Concentrate of proteolytic enzymes enriched in bromelain) - PSUSA - Modification - Commission Decision (2018)6460 of Tue, 02 Oct 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/10028/201712

Europe -DG Health and Food Safety

10-5-2018

Inhalation and nasal spray registered medicines

Inhalation and nasal spray registered medicines

New information about application pathways and data requirements for inhalation and nasal spray registered medicines

Therapeutic Goods Administration - Australia